Cargando…

Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats

BACKGROUND: Increased oxidative stress and impaired antioxidant defense are important mechanisms in the pathogenesis of diabetic myopathy. Alpha-lipoic acid (ALA) has been indicated as a weight-loss treatment in rodents and humans, but studies are limited. In the present study, we aimed to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Oak-Kee, Son, Jang-Won, Kwon, Hyuk-Sang, Lee, Seong-Su, Kim, Sung-Rae, Yoo, Soon Jib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162899/
https://www.ncbi.nlm.nih.gov/pubmed/30275871
http://dx.doi.org/10.1186/s12986-018-0302-y
_version_ 1783359247682109440
author Hong, Oak-Kee
Son, Jang-Won
Kwon, Hyuk-Sang
Lee, Seong-Su
Kim, Sung-Rae
Yoo, Soon Jib
author_facet Hong, Oak-Kee
Son, Jang-Won
Kwon, Hyuk-Sang
Lee, Seong-Su
Kim, Sung-Rae
Yoo, Soon Jib
author_sort Hong, Oak-Kee
collection PubMed
description BACKGROUND: Increased oxidative stress and impaired antioxidant defense are important mechanisms in the pathogenesis of diabetic myopathy. Alpha-lipoic acid (ALA) has been indicated as a weight-loss treatment in rodents and humans, but studies are limited. In the present study, we aimed to determine the influence of ALA, a potent biological antioxidant, on metabolic and growth processes in diabetic rat skeletal muscle. METHODS: Male 25-week-old type 2 diabetic rats (OLETF) were randomly divided into two groups, a control group (OLETF-C) and an ALA-treated group (OLETF-ALA) supplemented with 100 mg/kg ALA for 8 weeks. Age-matched, healthy, nondiabetic LETO (LETO-C) rats were used as controls. RESULTS: At 32 weeks of age, body weight was decreased by 6.8%, and the areas under the curve of IP-GTT, fasting glucose, and insulin were less in OLETF-ALA rats compared with OLETF-C rats. ALA significantly preserved muscle mass and enhanced muscle fiber cross-sectional area and fiber frequency percentage in the skeletal muscle of OLETF rats. Although the activation of myoD, myogenin, and myostatin in gastrocnemius muscle was significantly inhibited in OLETF-ALA rats relative to OLETF-C rats, there were no differences in the expression levels of muscle atrogin-1 and MuRF1 between the two groups. ALA treatment significantly increased the levels of phosphorylated 5′-AMPK, SIRT1, and PGC-1α, as well as the levels of phosphorylated AKT, mTOR, and p70S6 kinase in OLETF-ALA rats compared with OLETF-C rats. In contrast, the levels of phosphorylated p38 MAPK, IRS-1, and FOXO1 were decreased in OLETF-ALA rats compared with OLETF-C rats. CONCLUSIONS: ALA treatment preserved mass in the gastrocnemius muscles of OLETF rats. ALA significantly upregulated the AMPK/SIRT1/PGC-1α and AKT/mTOR/p70S6K signaling pathways in OLETF rat skeletal muscle. Therefore, ALA may be a potential therapeutic intervention for skeletal muscle loss in animal models of insulin resistance.
format Online
Article
Text
id pubmed-6162899
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61628992018-10-01 Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats Hong, Oak-Kee Son, Jang-Won Kwon, Hyuk-Sang Lee, Seong-Su Kim, Sung-Rae Yoo, Soon Jib Nutr Metab (Lond) Research BACKGROUND: Increased oxidative stress and impaired antioxidant defense are important mechanisms in the pathogenesis of diabetic myopathy. Alpha-lipoic acid (ALA) has been indicated as a weight-loss treatment in rodents and humans, but studies are limited. In the present study, we aimed to determine the influence of ALA, a potent biological antioxidant, on metabolic and growth processes in diabetic rat skeletal muscle. METHODS: Male 25-week-old type 2 diabetic rats (OLETF) were randomly divided into two groups, a control group (OLETF-C) and an ALA-treated group (OLETF-ALA) supplemented with 100 mg/kg ALA for 8 weeks. Age-matched, healthy, nondiabetic LETO (LETO-C) rats were used as controls. RESULTS: At 32 weeks of age, body weight was decreased by 6.8%, and the areas under the curve of IP-GTT, fasting glucose, and insulin were less in OLETF-ALA rats compared with OLETF-C rats. ALA significantly preserved muscle mass and enhanced muscle fiber cross-sectional area and fiber frequency percentage in the skeletal muscle of OLETF rats. Although the activation of myoD, myogenin, and myostatin in gastrocnemius muscle was significantly inhibited in OLETF-ALA rats relative to OLETF-C rats, there were no differences in the expression levels of muscle atrogin-1 and MuRF1 between the two groups. ALA treatment significantly increased the levels of phosphorylated 5′-AMPK, SIRT1, and PGC-1α, as well as the levels of phosphorylated AKT, mTOR, and p70S6 kinase in OLETF-ALA rats compared with OLETF-C rats. In contrast, the levels of phosphorylated p38 MAPK, IRS-1, and FOXO1 were decreased in OLETF-ALA rats compared with OLETF-C rats. CONCLUSIONS: ALA treatment preserved mass in the gastrocnemius muscles of OLETF rats. ALA significantly upregulated the AMPK/SIRT1/PGC-1α and AKT/mTOR/p70S6K signaling pathways in OLETF rat skeletal muscle. Therefore, ALA may be a potential therapeutic intervention for skeletal muscle loss in animal models of insulin resistance. BioMed Central 2018-09-29 /pmc/articles/PMC6162899/ /pubmed/30275871 http://dx.doi.org/10.1186/s12986-018-0302-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hong, Oak-Kee
Son, Jang-Won
Kwon, Hyuk-Sang
Lee, Seong-Su
Kim, Sung-Rae
Yoo, Soon Jib
Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats
title Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats
title_full Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats
title_fullStr Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats
title_full_unstemmed Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats
title_short Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats
title_sort alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic oletf rats
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162899/
https://www.ncbi.nlm.nih.gov/pubmed/30275871
http://dx.doi.org/10.1186/s12986-018-0302-y
work_keys_str_mv AT hongoakkee alphalipoicacidpreservesskeletalmusclemassintype2diabeticoletfrats
AT sonjangwon alphalipoicacidpreservesskeletalmusclemassintype2diabeticoletfrats
AT kwonhyuksang alphalipoicacidpreservesskeletalmusclemassintype2diabeticoletfrats
AT leeseongsu alphalipoicacidpreservesskeletalmusclemassintype2diabeticoletfrats
AT kimsungrae alphalipoicacidpreservesskeletalmusclemassintype2diabeticoletfrats
AT yoosoonjib alphalipoicacidpreservesskeletalmusclemassintype2diabeticoletfrats